Xtl Biopharmaceuticals (XTLB) Payables (2009 - 2025)
Xtl Biopharmaceuticals' Payables came in at $289,000 for the quarter ended Dec 31, 2025, down 68.9% from $928,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Payables (2009 - 2025) Analysis & Trends
Going back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Payables data covers 47 quarters.
- Payables carries a five-year compound annual growth rate of 2.6% (years ended Dec 2020 to Dec 2025).
- Going back by year, Payables was $928,000 in the year ended Dec 31, 2024 (+350.5%), $206,000 in the year ended Dec 31, 2023 (+10.2%), $187,000 in the year ended Dec 31, 2022 (-19.0%) and $231,000 in the year ended Dec 31, 2021 (-9.1%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Payables since the quarter ended Jun 30, 2024.
- Year-over-year, Payables increased in four of the last six quarters, with growth averaging 134.0%.
- The fastest year-over-year change in Payables over five years came in the quarter ended Dec 31, 2024 (growth of 350.5%), and the weakest in the quarter ended Dec 31, 2025 (a decline of 68.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Xtl Biopharmaceuticals | 2.11 Bn | 2.11 Bn | - | 289,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 289,000.00 |
| Jun 30, 2025 | 638,000.00 |
| Dec 31, 2024 | 928,000.00 |
| Sep 30, 2024 | 554,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 172,000.00 |
| Dec 31, 2021 | 231,000.00 |
| Jun 30, 2021 | 258,000.00 |
| Dec 31, 2020 | 254,000.00 |
| Dec 31, 2019 | 232,000.00 |
| Dec 31, 2018 | 253,000.00 |
| Dec 31, 2017 | 300,000.00 |
| Dec 31, 2016 | 17,000.00 |
API Access
Xtl Biopharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();